NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Calla Lily Clinical Care

Calla Lily Clinical Care

Private
LondonHealthcare & Life Scienceshttps://www.callali.ly/

Last Round

Pre Seed

Jun 1, 2025

Total Funding Raised

$7.35M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Calla Lily Clinical Care is a medical device company that develops patented, leak-resistant intravaginal drug delivery platforms for women's health applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

drug deliveryintravaginal drug deliverywomen's healthmedical devicedrug-device combinationfemtechbiotechnologyclinical trialdrug bioavailabilitylocalized drug releasetherapeutic deliverypharma partnershipdrug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Calla Lily Clinical Care Comparables

Compare Calla Lily Clinical Care with similar companies based on industry and business-model similarity.

Calla Lily Clinical Care comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LiGalli B.V.
84%
Gynica
80%
Evestra, Inc.
79%

Calla Lily Clinical Care Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedJun 1, 2025
Early FundingMay 13, 2025
GrantApr 3, 2025
AcceleratorMar 26, 2025
SeedJan 1, 2025
Seed
Mar 31, 2024

Key People

Founding team and executive leadership

Thang Vo-Ta

CEO Co-Founder

Founding Team

Akeel Khan

Chief Product Officer

Executive Team

Calla Lily Clinical Care Investors

Notable investors and investment history

Calla Lily Clinical Care investors
InvestorRounds
Innovate UKGrant
Springboard EnterprisesAccelerator
National Institute for Health and Care ResearchGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 10, 2026

    Partnered with Merck on an intravaginal drug delivery platform.

  • Aug 29, 2025

    Developing a novel vaginal platform technology for women's health.

Calla Lily Clinical Care Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Calla Lily Clinical Care Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Calla Lily Clinical Care's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range29
Year Founded2021
Last FundingJun 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.